AJANTA PHARMA LTD. - Outcome of Board Meeting

Download	< Back
31 Oct 2017
At the Board meeting held today, the Board has inter alia approved and taken on record Unaudited Financial results for the second quarter and half year ended 30th September 2017. Pursuant to Regulation 33 the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following:<BR> <BR> i. Press Release being issued on the Results for the second quarter and half year ended 30th September 2017;<BR> ii. Unaudited Consolidated Financial Results for the second quarter and half year ended 30th September 2017;<BR> iii. Limited Review Report from Auditors M/s BSR & Co. LLP on the unaudited Consolidated Financial Results for the second quarter and half year ended 30th September 2017;<BR> iv. Unaudited Standalone Financial Results for the second quarter and half year ended 30th September 2017;<BR> v. Limited Review Report from Auditors M/s BSR & Co. LLP on the unaudited Standalone Financial Results for the second quarter and half year ended 30th September 2017.<BR>
View all announcements for AJANTA PHARMA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us